12:00 AM
 | 
Dec 20, 2004
 |  BC Week In Review  |  Company News  |  Deals

AltaRex, ViRexx Medical deal

Cancer and hepatitis B company VIR completed its acquisition of cancer company ALT. ALT shareholders received 0.5 VIR shares for each ALT share, valuing ALT...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >